Latest News
Board Announcement – Appointment of new CEO
HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.
BioMimics 3D US launch
Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly-differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up.
36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live
Professor Thomas Zeller (University Heart Centre Freiburg, Bad Krozingen, Germany) today presented the 36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live.
The BioMimics 3D Vascular Stent System approved in Japan
The BioMimics 3D Vascular Stent System received Shonin regulatory approval in Japan.
MIMICS-2 at 1 year: 3D stent meets safety & effectiveness goals
The TCTMD reports on Timothy Sullivan's presentation at the International Symposium on Endovascular Therapy.
BioMimics 3D – The Swirling Flow Stent: 4 experts share their views
Vascular news advertorial.
NUI Galway will confer six leaders of the Irish medical technology sector with honorary degrees
NUI Galway will confer six outstanding leaders of the Irish medical technology (medtech) sector with honorary degrees on Monday 26 September.
CX Daily news 2016 – Good day for drug-coated balloons, swirling flow stents and drug-eluting stents
Professor Peter Gaines, Sheffield,UK, made the case for why inducing swirling flow improves the outcome from endovascular procedures…
Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients
PARIS, France—A “3D” helical stent that mimics the natural vascular curvature helps improve clinical symptoms and walking distance at 12 months in patients with femoropopliteal disease, according to results…
Galway’s Shortcut to Global Success with its Med-Tech Startups
The city’s med tech cluster has been the springboard for a start-up which, armed with almost €30m in funding, is on the cusp of a global breakthrough.
Imperial Innovations Group Plc – Uncovering the unquoted potential
Imperial Innovations has made significant progress in continuing not only to create new, exciting and innovative companies, but in nurturing existing companies towards important inflection points.
Imperial Innovations Set to Increase Investment in Veryan Medical
The technology transfer, incubation and venture investment company Imperial Innovations, Veryan’s largest investor with a 44.3% shareholding, is proposing to increase its investment in the company, in order to help fund future growth…
Featured story
01 September 2022
Board Announcement –
Appointment of new CEO
HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.
